Abstract submission is now open.
SUBMISSION DEADLINE: Friday, December 13, 2024
NOTIFICATION DATE: Friday, December 20, 2024
We invite all registered meeting attendees to submit abstracts for poster presentation for their latest research in cardiology the following topics:
- Arrhythmias
- Atherosclerosis and Thrombosis
- Cardiometabolic Health and Cardiovascular Prevention
- Cardiovascular Dysfunction
- Valvular Heart Disease
- Special Topics
At least one (1) author must be registered for the in-person meeting to have their abstracts considered for oral presentation and/or poster display. All submissions accepted for oral presentation must also create a poster for display.
All accepted abstracts will be displayed at the Going Back to the Heart of Cardiology Conference to be held at the Fontainebleau Hotel, Miami, Florida, January 24-26, 2025.
In addition, approved abstracts will also be submitted and indexed through our partner brand Read by QxMD. The platform drives awareness, dissemination and engagement with this content via the Read by QxMD platform, as an educational tactic to drive CQI. ‘Read’ works on iPhone, iPad, Android smartphones & tablets and any web-enabled device (including desktops), and uses channels such as mobile, email and push notification to connect with our global community of healthcare providers and researchers.
Download the App:
If you are returning to complete or check the status of your submission, please sign-in (link sign-in to the main sign-in page of the abstract page and then delete this parentheses) using your email address and password.
Fee: No fee for non-industry-sponsored abstracts; $495 per abstract for industry-sponsored abstracts. At least one (1) author must be registered for the in-person meeting to have their abstracts considered poster display
Encore posters are welcome!
Abstract Formatting and Content Guidelines
You must be registered for the meeting to have your abstract considered for a presentation.
- Language: English
- Authors: full last name, first name, affiliations, degrees and contact information
- Font: Arial
- Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations)
- Maximum of 2 relevant tables or figures submitted as attachments (not embedded in the file): must be 600 dpi .jpg
- Author(s) disclosures must be included to be considered.
- References must be included as parenthetical in-text citations - first author, et al, journal and year - (Cruz D, et al. Blood 2012)
- Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email)
- Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, Disclosures and Conclusions.
- Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted.
Please note that abstracts will not be accepted if the presenting author’s name is not bolded, presenting author’s email is not included and all faculty disclosures are not listed.
If you have any questions, please contact Tristan Nelsen at tnelsen@medscapelive.com.